These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961 [TBL] [Abstract][Full Text] [Related]
9. Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice. Melamed S; Paran N; Katz L; Ben-Nathan D; Israely T; Schneider P; Levin R; Lustig S Vaccine; 2007 Nov; 25(45):7743-53. PubMed ID: 17928110 [TBL] [Abstract][Full Text] [Related]
10. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917 [TBL] [Abstract][Full Text] [Related]
11. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination. Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294 [TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946 [TBL] [Abstract][Full Text] [Related]
13. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492 [TBL] [Abstract][Full Text] [Related]
14. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination. Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471 [TBL] [Abstract][Full Text] [Related]
15. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406 [TBL] [Abstract][Full Text] [Related]
16. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing. Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184 [TBL] [Abstract][Full Text] [Related]
18. Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination. Klote MM; Ludwig GV; Ulrich MP; Black LA; Hack DC; Engler RJ; Martin BL Ann Allergy Asthma Immunol; 2005 Jun; 94(6):682-5. PubMed ID: 15984602 [TBL] [Abstract][Full Text] [Related]
19. Ocular complications in the Department of Defense Smallpox Vaccination Program. Fillmore GL; Ward TP; Bower KS; Dudenhoefer EJ; Grabenstein JD; Berry GK; Madigan WP Ophthalmology; 2004 Nov; 111(11):2086-93. PubMed ID: 15522376 [TBL] [Abstract][Full Text] [Related]